3/21
10:49 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $8.00 price target on the stock.
Low
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $8.00 price target on the stock.
3/21
08:09 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its price target lowered by analysts at HC Wainwright from $17.50 to $13.00. They now have a "buy" rating on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its price target lowered by analysts at HC Wainwright from $17.50 to $13.00. They now have a "buy" rating on the stock.
3/21
08:09 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its price target lowered by analysts at Stifel Nicolaus from $12.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its price target lowered by analysts at Stifel Nicolaus from $12.00 to $5.00. They now have a "buy" rating on the stock.
3/20
08:14 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $7.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $7.00 price target on the stock.
3/20
04:05 pm
vor
Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
Low
Report
Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
2/14
09:09 pm
vor
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update [Yahoo! Finance]
Medium
Report
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update [Yahoo! Finance]
2/14
09:09 pm
vor
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer [Yahoo! Finance]
2/13
09:40 am
vor
Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials [Yahoo! Finance]
Low
Report
Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials [Yahoo! Finance]
2/13
08:00 am
vor
Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials
Medium
Report
Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials
2/3
08:00 am
vor
Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Low
Report
Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
1/21
04:37 pm
vor
Vor Biopharma files to sell 125.7M shares of common stock by selling shareholders [Seeking Alpha]
Low
Report
Vor Biopharma files to sell 125.7M shares of common stock by selling shareholders [Seeking Alpha]